胆管癌合并原发性血小板增多症1例报告

陆尧; 傅磊; 沈磊; 卞建军; 葛书亚

doi:10.3969/j.issn.1001-5256.2021.08.038

胆管癌合并原发性血小板增多症1例报告

DOI: 10.3969/j.issn.1001-5256.2021.08.038

蚌埠医学院第二附属医院血液内科，安徽蚌埠 233020

基金项目:

蚌埠医学院自然科学类基金 (BYKY2019156ZD)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：陆尧负责课题设计，资料分析，撰写论文；沈磊、卞建军、葛书亚参与收集数据，修改论文；傅磊负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
傅磊，mdbaby1513@163.com

中图分类号: R735.8
计量
- 文章访问数: 465
- HTML全文浏览量: 127
- PDF下载量: 33
- 被引次数: 0
出版历程
- 收稿日期: 2020-12-27
- 录用日期: 2021-02-05
- 出版日期: 2021-08-20

Cholangiocarcinoma with essential thrombocythemia: A case report

Department of Hematology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233020, China

Research funding:

Natural Science Fund of Bengbu Medical College (BYKY2019156ZD)

摘要

- 胆管肿瘤 /
- 血小板增多, 原发性 /
- 诊断
- Bile Duct Neoplasms /
- Thrombocythemia, Essential /
- Diagnosis

HTML全文

图 1 上腹部增强CT结果

注：a，肝内胆管扩张；b，胆总管扩张；c，胆总管占位；d，脾脏形态及大小正常。

下载: 全尺寸图片幻灯片

图 2 骨髓涂片结果(瑞氏染色，×1000)

注：显微镜下可见成堆大量血小板。

下载: 全尺寸图片幻灯片

参考文献(25)

[1]	CHEN E, MULLALLY A. How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?[J]. Hematology Am Soc Hematol Educ Program, 2014, 2014(1): 268-276. DOI: 10.1182/asheducation-2014.1.268.
[2]	TEFFERI A, GUGLIELMELLI P, LARSON DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis[J]. Blood, 2014, 124(16): 2507-2513; quiz 2615. DOI: 10.1182/blood-2014-05-579136.
[3]	SCHAFER AI. Thrombocytosis[J]. N Engl J Med, 2004, 350(12): 1211-1219. DOI: 10.1056/NEJMra035363.
[4]	HARRISON CN, BAREFORD D, BUTT N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis[J]. Br J Haematol, 2010, 149(3): 352-375. DOI: 10.1111/j.1365-2141.2010.08122.x.
[5]	WEI C, ZHAO TC, ZHANG L, et al. A case of pseudo thrombocytosis caused by fragments of red blood cells[J]. Chin J Intern Med, 2020, 59(5): 380-381. DOI: 10.3760/cma.j.cn112138-20191203-00795. 魏冲, 赵天赐, 张路, 等. 红细胞碎片所致假性血小板增多一例[J]. 中华内科杂志, 2020, 59(5): 380-381. DOI: 10.3760/cma.j.cn112138-20191203-00795.
[6]	LARSEN PB, VIKESÅ J, FRⅡS-HANSEN L. EDTA-induced pseudothrombocytosis and citrate-induced platelet agglutination in a patient with Waldenstrom macroglobulinemia[J]. Clin Case Rep, 2017, 5(8): 1243-1247. DOI: 10.1002/ccr3.1035.
[7]	JU MK, FU RF, LI HY, et al. Clinical characteristic of "triple-negative" essential thrombocythaemia patients and mutation analysis by targeted sequencing[J]. J Exp Hematol, 2018, 26(4): 1137-1145. DOI: 10.7534/j.issn.1009-2137.2018.04.032. 鞠满凯, 付荣凤, 李慧媛, 等. 三阴性血小板增多症的患者特点及靶向基因测序分析[J]. 中国实验血液学杂志, 2018, 26(4): 1137-1145. DOI: 10.7534/j.issn.1009-2137.2018.04.032.
[8]	JAMES C, UGO V, LE COUÉDIC JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera[J]. Nature, 2005, 434(7037): 1144-1148. DOI: 10.1038/nature03546.
[9]	LEVINE RL, WADLEIGH M, COOLS J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis[J]. Cancer Cell, 2005, 7(4): 387-397. DOI: 10.1016/j.ccr.2005.03.023.
[10]	VANNUCCHI AM, BARBUI T, CERVANTES F, et al. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2015, 26(Suppl 5): v85-v99. DOI: 10.1093/annonc/mdv203.
[11]	LIU TT, QU XY, LIU AN, et al. Classical Hodgkin lymphoma with essential thrombocythemia: Report of one case and review of literature[J]. J Leukemia Lymphoma, 2017, 26(5): 294-296. DOI: 10.3760/cma.j.issn.1009-9921.2017.05.011. 刘婷婷, 屈晓燕, 刘爱宁, 等. 经典型霍奇金淋巴瘤并发原发性血小板增多症一例并文献复习[J]. 白血病·淋巴瘤, 2017, 26(5): 294-296. DOI: 10.3760/cma.j.issn.1009-9921.2017.05.011.
[12]	WEI ZL, HUANG LQ, WANG XH, et al. Coexistence of primary bone diffuse large B cell lymphoma complicated with primary thrombocythemia: A case report and literature review[J]. Chin J Pract Intern Med, 2016, 36(10): 915-918. DOI: 10.7504/nk2016090701. 韦中玲, 黄来全, 汪兴洪, 等. 原发性骨弥漫大B细胞淋巴瘤伴原发性血小板增多症1例报告并文献复习[J]. 中国实用内科杂志, 2016, 36(10): 915-918. DOI: 10.7504/nk2016090701.
[13]	CHEN Z, WANG Y, HUANG B, et al. Essential thrombocythemia complicated with primary central nervous system lymphoma: A case report[J]. Chin J Hematol, 2009, 30(12): 803. DOI: 10.3760/cma.j.issn.0253-2727.2009.12.019. 陈字, 汪寅, 黄波, 等. 原发性血小板增多症合并原发性中枢神经系统淋巴瘤一例[J]. 中华血液学杂志, 2009, 30(12): 803. DOI: 10.3760/cma.j.issn.0253-2727.2009.12.019.
[14]	XIE YP, ZHANG JJ, HUANG XL, et al. Gastric mucosa associated lymphoma complicated with essential thrombocythemia: A case report[J]. J Clin Hematol, 2010, 23(1): 48. DOI: 10.3969/j.issn.1004-2806.2010.01.019. 谢亚萍, 章金娟, 黄细莲, 等. 胃黏膜相关淋巴瘤并发原发性血小板增多症1例[J]. 临床血液学杂志, 2010, 23(1): 48. DOI: 10.3969/j.issn.1004-2806.2010.01.019.
[15]	ESKAZAN AE, ONGOREN S, AR MC, et al. Essential thrombocythemia and multiple myeloma: Two rare diseases in one patient[J]. Clin Lymphoma Myeloma Leuk, 2011, 11(5): 442-445. DOI: 10.1016/j.clml.2011.04.001.
[16]	HUANG J, LUO XH, ZHU Y, et al. Coexistence of multiple myeloma with essential thrombocythemia: A case report and literatures review[J]. Chin J Hematol, 2014, 35(8): 757-759. DOI: 10.3760/cma.j.issn.0253-2727.2014.08.022. 黄婧, 罗小华, 朱艳, 等. 多发性骨髓瘤伴原发性血小板增多症一例报告并文献复习[J]. 中华血液学杂志, 2014, 35(8): 757-759. DOI: 10.3760/cma.j.issn.0253-2727.2014.08.022.
[17]	KONDO H, SAKAI Y, TAKASO T. Coexistence of essential thrombocythemia and gastric cancer[J]. Rinsho Ketsueki, 1993, 34(2): 224-228.
[18]	FU L, LI L, ZUO JM, et al. Gastric cancer complicated with essential thrombocythemia: A case report[J]. J Chin Oncol, 2020, 26(4): 365-367. DOI: 10.11735/j.issn.1671-170X.2020.04.B019. 傅磊, 李亮, 左金曼, 等. 胃癌合并原发性血小板增多症1例[J]. 肿瘤学杂志, 2020, 26(4): 365-367. DOI: 10.11735/j.issn.1671-170X.2020.04.B019.
[19]	SUN L, LI LY. Lung cancer complicated with essential thrombocythemia: A case report[J]. J China-Japan Friendship Hosp, 2013, 27(5): 313, inside back cover. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRYH201305018.htm 孙丽, 李利亚. 肺癌合并原发性血小板增多症1例[J]. 中日友好医院学报, 2013, 27(5): 313, 封3. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRYH201305018.htm
[20]	LI SQ, QIN W, ZUO LH, et al. Hepatoblastoma in child with essential thrombocythemia: A case report[J]. Med & Pharm J Chin PLA, 2011, 23(4): 60. DOI: 10.3969/j.issn.2095-140X.2011.04.027. 李四强, 秦伟, 左立辉, 等. 儿童肝母细胞瘤合并原发性血小板增多症一例[J]. 解放军医药杂志, 2011, 23(4): 60. DOI: 10.3969/j.issn.2095-140X.2011.04.027.
[21]	SEEGOBIN K, GHARIA B, MAHARAJ S, et al. Coexistent breast cancer and essential thrombocythemia: How we addressed the therapeutic challenges[J]. Case Rep Hematol, 2018, 2018: 2080185. DOI: 10.1155/2018/2080185.
[22]	HIYOSHI M, NOZAWA H, INADA K, et al. Cecal cancer with essential thrombocythemia treated by laparoscopic ileocecal resection: A case report[J]. Surg Case Rep, 2019, 5(1): 101. DOI: 10.1186/s40792-019-0660-3.
[23]	BRABRAND M, FREDERIKSEN H. Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: Clinical implications[J]. Cancers (Basel), 2020, 12(10): 3061. DOI: 10.3390/cancers12103061.
[24]	MARCHETTI M, GHIRARDI A, MASCIULLI A, et al. Second cancers in MPN: Survival analysis from an international study[J]. Am J Hematol, 2020, 95(3): 295-301. DOI: 10.1002/ajh.25700.
[25]	DENG HM, DUAN HX. Current status of the research on targeted therapy for cholangiocarcinoma[J]. J Clin Hepatol, 2020, 36(12): 2856-2859. DOI: 10.3969/j.issn.1001-5256.2020.12.046. 邓海敏, 段华新. 胆管癌靶向治疗的研究现状[J]. 临床肝胆病杂志, 2020, 36(12): 2856-2859. DOI: 10.3969/j.issn.1001-5256.2020.12.046.